| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Australis Capital Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.02 |
| Beta | 1.13 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -82.76% |
| 3 Year Change | -94.44% |
| 5 Year Change | n/a |
| Change since IPO | -99.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| AUSA | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -0.6% |
| 1Y | -82.8% | 50.8% | 3.9% |
Return vs Industry: AUSA underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: AUSA underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| AUSA volatility | |
|---|---|
| AUSA Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: AUSA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AUSA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Terry Booth | www.ausacap.com |
Australis Capital Inc. operates as a cannabis company. It undertakes cannabis and non-cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, Kuwait, Southeast Asia, and Australia, as well as other jurisdictions. The company is headquartered in Las Vegas, Nevada.
Australis Capital Inc. Fundamentals Summary
| AUSA fundamental statistics | |
|---|---|
| Market cap | CA$8.75m |
| Earnings (TTM) | -CA$50.09m |
| Revenue (TTM) | CA$9.47m |
0.9x
P/S Ratio-0.2x
P/E RatioIs AUSA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AUSA income statement (TTM) | |
|---|---|
| Revenue | CA$9.47m |
| Cost of Revenue | CA$3.61m |
| Gross Profit | CA$5.87m |
| Other Expenses | CA$55.96m |
| Earnings | -CA$50.09m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 61.95% |
| Net Profit Margin | -528.67% |
| Debt/Equity Ratio | 5.4% |
How did AUSA perform over the long term?
See historical performance and comparison